In Vivo Scientist II

ARTBIO

3 months ago

Oslo, Norway

Onsite

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Scientist II, In Vivo Biology, will contribute to the advancement of ARTBIO’s pipeline of targeted radiotherapies for cancer treatment. Based in Oslo, this role focuses on preclinical in vivo oncology research supporting radioligand therapy development. The position sits within a small, agile biotech environment with strong cross-site and cross-functional collaboration. The scientist will also help represent ARTBIO in the broader scientific community through publications and conference presentations.

Skills

Qualifications

PhD in Biomedical SciencesPhD in PharmacologyPhD in RadiochemistryPhD in Medical PhysicsFELASA Category C

About ARTBIO

artbio.com

ARTBIO is a biotechnology company developing a new class of alpha radioligand therapies to redefine cancer care. The company is building an ecosystem — from targeted radioligand drug candidates and radiochemistry to manufacturing, clinical infrastructure, and partnerships — to maximize the potential of these potent targeted therapies. ARTBIO aims to accelerate development and broaden patient access by combining precision targeting, specialized delivery, and collaborative clinical programs.

Recent company news

PR Newswire

ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure

Jul 29, 2025